PATHOLOGY GUIDANCE DOCUMENT FOR IRB SUBMISSIONS
GENERAL STRUCTURE OF PATHOLOGY GUIDANCE DOCUMENT
METHODS
DEVELOPMENT
Scenario 1
METHODS DEVELOPMENT AND VALIDATION
METHODS
DEVELOPMENT
Scenario 1b
METHODS DEVELOPMENT AND VALIDATION
QUALITY ASSURANCE VS
RESEARCH
Nat’l Bioethics Advisory Committee
QUALITY ASSURANCE VS
RESEARCH
Nat’l Bioethics Advisory Committee
METHODS
DEVELOPMENT
Scenario 2
METHODS
DEVELOPMENT
Master Protocol
METHODS
DEVELOPMENT
Scenario 2
METHODS
DEVELOPMENT
Scenario 3
METHODS
DEVELOPMENT
Scenario 3
STUDIES ON ARCHIVAL
TISSUE
Scenario 1
STUDIES ON ARCHIVAL
TISSUE
Scenario 1
REQUESTS FOR
EXEMPTION
Key points to note in letter/email
STUDIES ON ARCHIVAL
TISSUE
Scenario 2
STUDIES ON ARCHIVAL
TISSUE
Identifiers retained
WAIVER OF INFORMED
CONSENT
Four Requirements under 45 CFR 46.116
STUDIES ON ARCHIVAL
TISSUE
Identifiers retained
PROCEDURE FOR AMENDING MASTER PROTOCOL
STUDIES ON ARCHIVAL
TISSUE
Scenario 3
STUDIES ON ARCHIVAL
TISSUE
Scenario 3